Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genome editing and the next generation of antiviral therapy
Daniel Stone, Nixon Niyonzima, Keith R. Jerome
Human Genetics (2016) Vol. 135, Iss. 9, pp. 1071-1082
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base Editing
Yu-Chan Yang, Yu‐Hsiang Chen, Jia‐Horng Kao, et al.
Molecular Therapy — Nucleic Acids (2020) Vol. 20, pp. 480-490
Open Access | Times Cited: 81
CRISPR-Cas9 gene editing of hepatitis B virus in chronically infected humanized mice
Daniel Stone, Kelly R. Long, Michelle A. Loprieno, et al.
Molecular Therapy — Methods & Clinical Development (2020) Vol. 20, pp. 258-275
Open Access | Times Cited: 78
CRISPR-Cas based antiviral strategies against HIV-1
Gang Wang, Na Zhao, Ben Berkhout, et al.
Virus Research (2017) Vol. 244, pp. 321-332
Open Access | Times Cited: 85
In Vivo Genome Editing as a Therapeutic Approach
Beatrice Xuan Ho, Sharon Jia Hui Loh, Woon‐Khiong Chan, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 9, pp. 2721-2721
Open Access | Times Cited: 72
Gene editing and elimination of latent herpes simplex virus in vivo
Martine Aubert, Daniel E. Strongin, Pavitra Roychoudhury, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 64
Optimization of AAV vectors to target persistent viral reservoirs
Rossana Colón-Thillet, Keith R. Jerome, Daniel Stone
Virology Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 42
Chronic Hepatitis B Infection: New Approaches towards Cure
Mojisola Ogunnaike, Srijanee Das, Samiksha S. Raut, et al.
Biomolecules (2023) Vol. 13, Iss. 8, pp. 1208-1208
Open Access | Times Cited: 19
The Impact of HIV-1 Genetic Diversity on CRISPR-Cas9 Antiviral Activity and Viral Escape
Gilles Darcis, Caroline S. Binda, Bep Klaver, et al.
Viruses (2019) Vol. 11, Iss. 3, pp. 255-255
Open Access | Times Cited: 38
Identification of the differential expression of genes and upstream microRNAs in small cell lung cancer compared with normal lung based on bioinformatics analysis
Xiuwei Li, Chao Ma, Huan Luo, et al.
Medicine (2020) Vol. 99, Iss. 11, pp. e19086-e19086
Open Access | Times Cited: 36
Evaluation of the Anti-cancer Effect of Syzygium cumini Ethanolic Extract on HT-29 Colorectal Cell Line
Amir Khodavirdipour, Rana Zarean, Reza Safaralizadeh
Journal of Gastrointestinal Cancer (2020) Vol. 52, Iss. 2, pp. 575-581
Closed Access | Times Cited: 33
CRISPR/CasRx: A novel antiviral approach to combat largemouth bass (Micropterus salmoides) Rhabdovirus infections
Kechen Yang, B.M. Ma, Zhongxin Wu, et al.
Aquaculture (2025), pp. 742189-742189
Closed Access
Elimination of infectious HIV DNA by CRISPR–Cas9
Atze T. Das, Caroline S. Binda, Ben Berkhout
Current Opinion in Virology (2019) Vol. 38, pp. 81-88
Open Access | Times Cited: 35
Recent progress on the CRISPR/Cas system in optical biosensors
Bingqian Li, Guangyu Zhai, Yaru Dong, et al.
Analytical Methods (2024) Vol. 16, Iss. 6, pp. 798-816
Closed Access | Times Cited: 3
Multiplex CRISPR/Cas9 system impairs HCMV replication by excising an essential viral gene
Janina Gergen, Flora Coulon, Alison Crénéguy, et al.
PLoS ONE (2018) Vol. 13, Iss. 2, pp. e0192602-e0192602
Open Access | Times Cited: 31
ABL Genomic Editing Sufficiently Abolishes Oncogenesis of Human Chronic Myeloid Leukemia Cells In Vitro and In Vivo
Shu-Huey Chen, Yao-Yu Hsieh, Huey-En Tzeng, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1399-1399
Open Access | Times Cited: 24
The therapeutic landscape of HIV-1 via genome editing
Alexander Kwarteng, Samuel Terkper Ahuno, Godwin Kwakye-Nuako
AIDS Research and Therapy (2017) Vol. 14, Iss. 1
Open Access | Times Cited: 26
Clinical potential of oligonucleotide-based therapeutics in the respiratory system
Sterghios Moschos, Louise Usher, Mark A. Lindsay
Pharmacology & Therapeutics (2016) Vol. 169, pp. 83-103
Open Access | Times Cited: 25
Fluorescent RNA cytosine analogue – an internal probe for detailed structure and dynamics investigations
Anders Foller Füchtbauer, Søren Preus, Karl Börjesson, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 24
Epigenetic Treatment of Persistent Viral Infections
Walter H. Moos, Carl A. Pinkert, Michael H. Irwin, et al.
Drug Development Research (2016) Vol. 78, Iss. 1, pp. 24-36
Closed Access | Times Cited: 22
Expression of nerve growth factor carried by pseudotyped lentivirus improves neuron survival and cognitive functional recovery of post‐ischemia in rats
Jiayu Cao, Yong Lin, Yanfei Han, et al.
CNS Neuroscience & Therapeutics (2018) Vol. 24, Iss. 6, pp. 508-518
Open Access | Times Cited: 21
Adenovirus Vectors Expressing Eight Multiplex Guide RNAs of CRISPR/Cas9 Efficiently Disrupted Diverse Hepatitis B Virus Gene Derived from Heterogeneous Patient
Yuya Kato, Hirotaka Tabata, Kumiko Sato, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10570-10570
Open Access | Times Cited: 17
Towards precision medicine
Tanya Bardakjian, Pedro Gonzalez‐Alegre
Handbook of clinical neurology (2018), pp. 93-102
Closed Access | Times Cited: 19
Single-Domain Antibodies Represent Novel Alternatives to Monoclonal Antibodies as Targeting Agents against the Human Papillomavirus 16 E6 Protein
Melissa Togtema, Greg Hussack, Guillem Dayer, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 9, pp. 2088-2088
Open Access | Times Cited: 16
CRISPR/Cas9 and Genome Editing for Viral Disease—Is Resistance Futile?
Harshana S. De Silva Feelixge, Daniel Stone, Pavitra Roychoudhury, et al.
ACS Infectious Diseases (2018) Vol. 4, Iss. 6, pp. 871-880
Open Access | Times Cited: 16
Engineered RNase P Ribozymes Effectively Inhibit the Infection of Murine Cytomegalovirus in Animals
Wei Li, Yujun Liu, Yuanyuan Wang, et al.
Theranostics (2018) Vol. 8, Iss. 20, pp. 5634-5644
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top